Endogenous opioid peptides contribute to antinociceptive potency of intrathecal [Dmt1]DALDA

Journal of Pharmacology and Experimental Therapeutics

Volumn 305, Issue 2, 2003, Pages 696-702

  Szeto, Hazel H ^a   Soong, Yi ^a   Wu, Dunli ^a   Qian, Xuanxuan ^a   Zhao, Guo Min ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DELTA OPIATE RECEPTOR; DERMORPHIN DERIVATIVE; DYNORPHIN A; GUANOSINE 5' O (3 THIOTRIPHOSPHATE) S 35; H 2',6' DIMETHYLTYROSINE DEXTRO ARGINYLPHENYLALANYLLYSINAMIDE; KAPPA OPIATE RECEPTOR; METENKEPHALIN; MORPHINE; MU OPIATE RECEPTOR; NALTRIBEN; NORBINALTORPHIMINE; OPIATE RECEPTOR; SULFUR DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; ATTENUATION; BINDING AFFINITY; CELL MEMBRANE; CONTROLLED STUDY; DRUG POTENCY; DRUG SELECTIVITY; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SPINAL CORD; TAIL FLICK TEST;

ANALGESICS, OPIOID; ANIMALS; ANTIBODIES, BLOCKING; CLONING, MOLECULAR; DYNORPHINS; ENDORPHINS; ENKEPHALIN, METHIONINE; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HEAT; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SPINAL; MALE; MICE; NALOXONE; NALTREXONE; NARCOTIC ANTAGONISTS; OLIGOPEPTIDES; PAIN MEASUREMENT; RADIOLIGAND ASSAY; REACTION TIME; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU;

EID: 0037404422     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.048561     Document Type: Article

References (29)

1. Bakshi R, Ni R-X, and Faden AI (1992) N-Methyl-D-aspartate (NMDA) and opioid receptors mediate dynorphin-induced spinal cord injury: behavioral and histological studies. Brain Res 580:255-264.
2. 2+-regulated transcriptional repressor. Nature (Lond) 398:80-84.
3. Cheng HY, Pitcher GM, Laviolette SR, Whishaw IQ, Tong KI, Kockeritz LK, Wada T, Joza NA, Crackower M, Goncalves J, et al. (2002) DREAM is a critical transcriptional repressor for pain modulation. Cell 108:31-43.
4. 50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3102.
5. Haley TJ and McCormick WG (1957) Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse. Br J Pharmacol Chemother 12:12-15.
6. He L and Lee NM (1998) Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord. J Pharmacol Exp Ther 285:1181-1186.
7. Hylden JL and Wilcox GL (1980) Intrathecal morphine in mice: a new technique. Eur J Pharmacol 67:313-316.
8. Laughlin TM, Vanderah TW, Lashbrook J, Nichols ML, Ossipov M, Porreca F, and Wilcox GL (1997) Spinally administered dynorphin A produces long-lasting allodynia: involvement of NMDA but not opioid receptors. Pain 72:253-260.
9. Lee NM, Leybin L, Chang JK, and Loh HH (1980) Opiate and peptide interaction: effect of enkephalins on morphine analgesia. Eur J Pharmacol 68:181-185.
10. 2-opioid binding in the mouse central nervous system. Brain Res 360:117-129.
11. Neilan CL, Nguyen TM, Schiller PW, and Pasternak GW (2001) Pharmacological characterization of the dermorphin analog [Dmt(1)]DALDA, a highly potent and selective mu-opioid peptide. Eur J Pharmacol 419:15-23.
12. Ohsawa M, Mizoguchi H, Narita M, Nagase H, Kampine JP, and Tseng LF (2001) Differential antinociception induced by spinally administered endomorphin-1 and endomorphin-2 in the mouse. J Pharmacol Exp Ther 298:592-597.
13. Porreca F, Takemori AE, Sultana M, Portoghese PS, Bowen WD, and Mosberg HI (1992) Modulation of mu-mediated antinociception in the mouse involves opioid delta-2 receptors. J Pharmacol Exp Ther 263:147-152.
14. Randic M, Cheng G, and Kojic L (1995) Kappa-opioid receptor agonists modulate excitatory transmission in substantia gelatinosa neurons of the rat spinal cord. J Neurosci 15:6809-6826.
15. 1]DALDA is highly selective and potent at mu opioid receptors, but is not cross-tolerant with systemic morphine. Curr Med Chem 9:31-39.
16. Sakurada S, Hayashi T, Yuhki M, Fujimura T, Murayama K, Yonezawa A, Sakurada C, Takeshita M, Zadina JE, Kastin AJ, and Sakurada T (2000) Differential antagonism of endomorphin-1 and endomorphin-2 spinal antinociception by naloxonazine and 3-methoxynaltrexone. Brain Res 881:1-8.
17. Sakurada S, Hayashi T, Yuhki M, Orito T, Zadina JE, Kastin AJ, Fujimura T, Murayama K, Sakurada C, Sakurada T, et al. (2001) Differential antinociceptive effects induced by intrathecally administered endomorphin-1 and endomorphin-2 in the mouse. Eur J Pharmacol 427:203-210.
18. Sakurada S, Zadina JE, Kastin AJ, Katsuyama S, Fujimura T, Murayama K, Yuki M, Ueda H, and Sakurada T (1999) Differential involvement of mu-opioid receptor subtypes in endomorphin-1 and -2-induced antinociception. Eur J Pharmacol 372:25-30.
19. Schiller PW, Nguyen TM, Berezowska I, Dupuis S, Weltrowska G, Chung NN, and Lemieux C (2000) Synthesis and in vitro opioid activity profiles of DALDA analogues. Eur J Med Chem 35:895-901.
20. Schiller PW, Nguyen TM, Chung NN, and Lemieux C (1989) Dermorphin analogues carrying an increased positive net charge in their "message" domain display extremely high mu opioid receptor selectivity. J Med Chem 32:698-703.
21. 2 (DALDA) and [Dmt1] DALDA. J Pharmacol Exp Ther 297:364-371.
22. 2-opioid receptors in the brain and spinal cord, respectively. Eur J Pharmacol 242:145-150.
23. Vanderah TW, Gardell LR, Burgess SE, Ibrahim M, Dogrul A, Zhong CM, Zhang ET, Malan TP Jr, Ossipov MH, Lai J, and Porreca F (2000) Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance. J Neurosci 20:7074-7079.
24. Vanderah TW, Laughlin T, Lashbrook JM, Nichols ML, Wilcox GL, Ossipov MH, Malan TP Jr, and Porreca F (1996) Single intrathecal injections of dynorphin A or des-Tyr-dynorphins produce long-lasting allodynia in rats: blockade by MK-801 but not naloxone. Pain 68:275-281.
25. Vanderah TW, Wild KD, Takemori AE, Sultana M, Portoghese PS, Bowen WD, Hruby VJ, Mosberg HI, and Porreca F (1993) Modulation of morphine antinociception by swim-stress in the mouse: involvement of supraspinal opioid delta-2 receptors. J Pharmacol Exp Ther 267:449-455.
26. Vaught JL and Takemori AE (1979) A further characterization of the differential effects of leucine enkephalin, methionine enkephalin and their analogs on morphine-induced analgesia. J Pharmacol Exp Ther 211:280-283.
27. Zachariou V and Goldstein BD (1997) Dynorphin-(1-8) inhibits the release of substance P-like immunoreactivity in the spinal cord of rats following a noxious mechanical stimulus. Eur J Pharmacol 323:159-165.
28. Zadina JE, Hackler L, Ge LJ, and Kastin AJ (1997) A potent and selective endogenous agonist for the μ-opiate receptor. Nature (Lond) 386:499-502.
29. Zhao GM, Wu D, Soong Y, Shimoyama M, Berezowska I, Schiller PW, and Szeto HH (2002) Profound spinal tolerance after repeated exposure to a highly selective mu-opioid peptide agonist: role of delta-opioid receptors. J Pharmacol Exp Ther 302:188-196.